Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Published August 1, 2024
Citation Information: JCI Insight. 2024;9(18):e182330. https://doi.org/10.1172/jci.insight.182330.
View: Text | PDF
Research Article Bone biology

HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation

  • Text
  • PDF
Abstract

Energy metabolism, through pathways such as oxidative phosphorylation (OxPhos) and glycolysis, plays a pivotal role in cellular differentiation and function. Our study investigates the impact of OxPhos disruption in cortical bone development by deleting mitochondrial transcription factor A (TFAM). TFAM controls OxPhos by regulating the transcription of mitochondrial genes. The cortical bone, constituting the long bones’ rigid shell, is sheathed by the periosteum, a connective tissue layer populated with skeletal progenitors that spawn osteoblasts, the bone-forming cells. TFAM-deficient mice presented with thinner cortical bone, spontaneous midshaft fractures, and compromised periosteal cell bioenergetics, characterized by reduced ATP levels. Additionally, they exhibited an enlarged periosteal progenitor cell pool with impaired osteoblast differentiation. Increasing hypoxia-inducible factor 1a (HIF1) activity within periosteal cells substantially mitigated the detrimental effects induced by TFAM deletion. HIF1 is known to promote glycolysis in all cell types. Our findings underscore the indispensability of OxPhos for the proper accrual of cortical bone mass and indicate a compensatory mechanism between OxPhos and glycolysis in periosteal cells. The study opens new avenues for understanding the relationship between energy metabolism and skeletal health and suggests that modulating bioenergetic pathways may provide a therapeutic avenue for conditions characterized by bone fragility.

Authors

Mohd P. Khan, Elena Sabini, Katherine Beigel, Giulia Lanzolla, Brittany Laslow, Dian Wang, Christophe Merceron, Amato Giaccia, Fanxin Long, Deanne Taylor, Ernestina Schipani

×

Figure 3

scRNA-Seq analysis of CTRL and TFAM mutant periosteal cells.

Options: View larger image (or click on image) Download as PowerPoint
scRNA-Seq analysis of CTRL and TFAM mutant periosteal cells.
(A) Uniform...
(A) Uniform manifold approximation and projection (UMAP) visualization of aggregate clusters. (B) A heatmap displaying the top 10 genes expressed in each cell subcluster. (C) UMAP visualization of the mitochondrial marker ATP synthase subunit 6 (mt-Atp6), a downstream target of TFAM. (D) UMAP analysis depicting the distribution of cell populations across clusters, comparing CTRL cells (in orange) with TFAM mutant cells (in light blue). (E) Nebulosa plot illustrating the UMAP distribution of cells coexpressing skeletal progenitor markers such as paired related homeobox 1 (Prx1), Thy-1 cell surface antigen (Cd90), platelet-derived growth factor receptor alpha (Pdgfra), and stem cell antigen-1 (Sca1) (skeletal progenitors) alongside cells coexpressing Bglap and alkaline phosphatase (Alpl) (osteoblast-like cells). (F) A bar graph comparing the percentage of periosteal cell subtypes in CTRL versus TFAM, with skeletal progenitors highlighted in brown and osteoblast-like cells in green. (G) Violin plots illustrating the expression of representative markers differentially expressed between CTRL and TFAM, including Bglap, collagen type I alpha 1 chain (Col1a1), serpin family H member 1 (Serpinh1), procollagen C-endopeptidase enhancer (Pcolce), cyclin-dependent kinase inhibitor 1A (Cdkn1a), and serpin family E member 1 (Serpine1). The data in the violin plots are shown as distributions, with the width of the plot representing the density of data points at different expression levels. Biological and technical duplicates were used in the analysis. Statistical analysis employed Wilcoxon’s signed-rank test, with significance denoted as ***P ≤ 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts